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ABSTRACT
Objective: Our study aims to evaluate the combined effect of Bacille Calmette–Guérin (BCG) and dexamethasone (DEX) on male mice undergoing 
behavioral testing (forced swimming test, elevated plus maze, tail suspension test, and sucrose intake). An intraperitoneal injection of 0.2 ml/mg of 
BCG and 0.1 ml/mg of DEX body weight was administered after all behavioral tests were applied.
Methods: This study is based on the distribution of 15 male mice in three groups: Controls, DEX, and DEX+BCG. These mice underwent behavioral tests.
Results: The result after administration of DEX and BCG was found after 10 days. We observed an increase in locomotors activity with some degree 
of anxiety.
Conclusion: This allowed us to conclude that the combination of DEX+BCG seems to play a depressinogenic effect that will develop to become 
antidepressive.
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INTRODUCTION
Anxiety is often used as a synonym for the word “stress.” There is no 
universally accepted definition of it. Some authors have defined it as a 
complex emotional state, a combination of feelings of fear, apprehension, 
and anxiety, often accompanied by instability or tension [1].
Disorders of various origins can accompany anxiety, leading to behavioral 
problems, affecting, for example, about 30% of the inhabitants of 
industrialized countries [2] and appear to be progressing. In rodents, 
anxiety is defined as a high level of apprehension of a new and unknown 
environment and of the increased reaction of fear [3-5]. When anxiety 
becomes abnormally intense, repetitive, prolonged, and inevitable, 
it can present a pathological form, leading to repressed behaviors, 
conditioned negative responses, and poor coping strategies [6,7].
First, we test the effect of Bacille Calmette–Guérin (BCG) on the 
neurobehavioral aspect of male mice.
The biliary vaccine of Calmette and Guérin, most commonly referred to 
as BCG vaccine, against tuberculosis. It is prepared from an attenuated 
strain of live bovine tuberculosis (Mycobacterium bovis) that has lost its 
virulence on man by special cultivation on artificial environments for 
years. This bacillus close to Mycobacterium tuberculosis, responsible for 
human tuberculosis, confers sufficient cross-antigenicity to become an 
effective vaccine for the prevention of human tuberculosis. It has also 
been used in veterinary medicine. The efficacy of the BCG vaccine has 
been the subject of a recurrent debate due to divergent test results [8].
The second step in our experiment was to see the combined effect of 
BCG and dexamethasone (DEX) on male mice (neurobehavioral aspect). 
It should be noted that DEX is a synthetic glucocorticoid hormone and 
has an anti-inflammatory effect and immunosuppressant (its potency 
is about 40 times that of cortisol) and is sometimes illegally used with 
other doping and anabolic agents in farms to make animals grow faster 
by increasing the protein content of meat [9].
The objective of this present study is examined the combined 




Our biological material is the white male mice M. musculus, aged 
6 months and average weight of 38 g±50 g from the Pasteur Institute 
of Algiers.
The animals are reared in polyethylene cages. They undergo an 
adaptation period of 4 weeks under the environmental conditions of the 
experimental room (natural photoperiod, humidity, and temperature). 
Their food consists of corn, barley, and milk and supplements Vitamins 
(GAE: Agricultural Group of the East, El Harrouch, Algeria). The mice 
are subjected to a natural photoperiodic regimen. Due to the extreme 
susceptibility of stress response systems to all kinds of aggression, 
we attach the almost importance to daily handling conditions and to 
the environment where noise is attenuated. Animal procedures were 
performed in accordance with the Ethics Committee of the National 
Research Center and followed the recommendations of the National 
Institutes of Health Guide for Care and Use of Laboratory Animals [10].
We selected 15 males according to weight (between 32 and 44 g) and 
we divided them into three experimental groups, five mice in each 




DEX is a type of corticosteroid medication. We injected a dose of DEX 
0.1 mg [11] for each mouse during the first 10 days of the period of 
experimental protocol, after 10 days, we repeated behavioral tests 
(forced swimming test [FST], tail suspension test [TST], elevated plus 
maze (EPM), and sucrose test).
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i8.32609
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BCG
BCG is a widely used tuberculosis vaccine derived from a non-infectious 
strain of bovine tuberculosis (M. bovis) and mainly administered to 
young children.
We injected a dose of BCG 0.2 mg [12] for each mouse during the 
first 10 days of the period of experimental protocol, after 10 days, we 
repeated behavioral tests (FST, TST, EPM, and sucrose test).
Neurobehavioral tests
FST
The FST is a behavioral model that predicts the effectiveness of 
antidepressant therapy [13-16]. This animal model, which is used 
in rats as well as in mice, nevertheless, has procedural differences 
depending on the species used. The test consists in placing the mouse 
in an aquarium 60 cm high by 20 cm wide. These dimensions make it 
possible to ensure that the rat cannot escape by clinging to the edges 
of the device. The aquarium is filled with 25°C water. The height of the 
water reaches 35 cm to ensure that the smile does not use its lower 
limbs to remain on the surface and, therefore, oblige it to swim. After a 
period of vigorous activity (adaptation time), the control animal stops 
swimming and freezes, adopting a behavior of despair. It is considered 
that the animal is immobile when it floats in a horizontal position and 
realizes only movements of small amplitude, sufficient to keep its head 
out of the water (Fig. 1).
The test lasts 6 min, but only the past 4 min of the test are used to record 
the swimming time. The variables are measured on the FST: Immobility 
time, swimming time, and climbing time.
EPM
The EPM test is used to measure the degree of anxiety in laboratory 
animals. The test uses an elevated, plus-shaped (+) apparatus with 
two open and two enclosed arms. The behavioral model is based on 
the general aversion of rodents to open spaces [17]. This aversion leads 
to the behavior termed a preference for remaining in enclosed spaces 
or close to the edges of a bounded space. In the EPM, this translates 
into the animals limiting their movement to the enclosed arm. Anxiety 
reduction is indicated in the plus maze by an increase in the proportion 
of time spent in the open arms (time in open arms/total time in open or 
closed arms), and an increase in the proportion of entries into the open 
arms (entries into open arms/total entries into open or closed arms). 
The total number of arm entries and number of closed-arm entries are 
sometimes used as measures of general activity [17,18] (Fig. 2).
TST
In 1985 (Steru et al., 1985) used the caudal suspension test for 
measures the immobility of the animal. A scotch is placed at the end 
of the caudal part of the animal, which allows suspending it by the tail 
to a hook. The hook is connected to a sensor that records movement 
variations for 6 min (Fig. 3).
After a period of exhaust mobility, the animal becomes immobilized and 
adopts a so-called despairing behavior [19].
Sucrose preference test (Sucrose intake)
This test is used only in indicator of anhedonia (lack of interest 
in rewarding stimuli), which is present in some forms of affective 
disorders including depression.
Before starting the test, rats are accustomed to the presence of two 
bottles of beverage (one containing water+sucrose and the other 
containing ordinary water) for 3 days in their cage. Following this 
acclimatization, the mice have the free choice of the solution either 
potable of sucrose or water for a period of 4 days. Water and sucrose 
solution is measured daily, and the positions of two bottles are switched 
daily to reduce any confound produced by side polarization. Sucrose 
preference is calculated as a percentage of the sucrose intake volume 
relative to the total volume of fluid intake and on average over the four 
test days [20] (Fig. 4).
Statistical analysis
Data are presented as mean ± standard error of the mean. Data were 
analyzed by one-way analysis of variance (ANOVA) and Student’s t-test. 
Results were considered statistically significant at p<0.05. GraphPad 
Prism 6 was used to do the analysis.
Fig. 1: Evolution of forced swimming test parameters: Immobility time (a) (sec), swimming time (sec) (b), and climbing time (sec) (c) in 
control, dexamethasone (DEX) group, and DEX+BCG group. Data are presented as mean±standard error of the mean. Data were analyzed 
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Analysis of the immobility time revealed a significant effect (p<0.05).
Climbing time
We used one-way ANOVA and Student’s t-test. The results obtained 
(histogram C) show that the climbing time in the controls is greater than that 
of the treated by DEX and lower than that of the treatments by DEX+BCG.
Analysis of the immobility time revealed a significant effect (p<0.05).
The EPM test
The measured parameters are: EPM test parameters in control, DEX 
group, and DEX+BCG: (A)Time spent in closed arms, (B)numbe of 
entries in the closed arms, (C) time spent in center device, and (D) 
number of entries in center device.
Time spent in closed arms
The results obtained (histogram A) show that the time spent in the 
closed arms of the device in the controls is greater than that of the 
treated by DEX and lower than that of the treated with DEX+BCG.
RESULTS
FST parameters
The measured elevated plus maze (EPM) parameters are: Swimming 
time (sec), immobility time (sec), and climbing time (sec) in control, 
DEX group, and DEX+BCG group.
Swimming time
We used one-way ANOVA and Student’s t-test. The results obtained 
(histograms A) show that the time of the swimming in the controls is 
lower than that of the treated by DEX and slightly higher than that of 
the treatments by DEX+BCG.
The analysis of swimming time revealed a significant effect (p<0.05).
Immobility time
We used one-way ANOVA and Student’s t-test. The results obtained 
(histogram B) show that the time of the immobility in the controls is 
greater than that of the treated by DEX and also superior to that of the 
DEX+BCG treatments.
Fig. 2: Elevated plus-maze test parameters in control, dexamethasone (DEX) group, and DEX+Bacille Calmette–Guérin (a): Time spent in 
closed arms (sec), (b) number of entries in closed arms, (c) time spent in center device (sec), (d) number of entries in center device. Data 
are presented as mean±standard error of the mean. Data were analyzed by one-way analysis of variance and Student’s t-test. Results were 





Fig. 3: Tail suspension test parameters in control mice, dexamethasone (DEX) treated, and DEX+Bacille Calmette–Guérin. (a) Mobility 
time (sec), (b) immobility time (sec). Data are presented as mean±standard error of the mean. Data were analyzed by one-way analysis of 
variance and Student’s t-test. Results were considered statistically significant at p<0.05 (n=5)
a b
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Analysis of the time spent in the closed arms revealed no significant 
effect (p<0.05).
Number of entries in closed arms
The results obtained (histogram B) show that there is an increase in 
the number of entries in the closed arms of the DEX-treated group 
compared to the controls and an increase in the DEX+BCG-treated 
group compared to the controls as well.
The analysis indicates that there is a significant effect (p<0.05).
Time spent in center device
The results obtained (histogram C) show that the time spent in the 
center of the device in the controls is lower than that of the DEX 
group treatments and slightly higher than that of the DEX+BCG group 
treatments.
Analysis of time spent in the center revealed no significant effect 
(p<0.05).
Number of entries in center device
The results obtained (histogram D) show that there is an increase in the 
number of entry (NE) in the center of the treatments by DEX compared 
to the controls, and an increase of the treatments by DEX+BCG group 
compared to the controls as well.
The analysis indicates that there is a significant effect (p<0.05).
TST
The measured tail suspension test parameters are: in control mice, DEX 
treated, and DEX+BCG.(A) Mobility time (sec),(B) immobility time (sec).
Mobility time
The results obtained (histogram A) show that the mobility time in the 
controls is greater than that of the treated by DEX and also superior to 
that of the DEX+BCG treatments.
The mobility time analysis revealed a significant effect (p<0.05).
Immobility time
The results obtained (histogram B) show that the time of the immobility 
in the controls is lower than that of the treated by DEX and also lower 
than that of the treatments by DEX+BCG group.
Analysis of the immobility time revealed a significant effect (p<0.05).
Sucrose intake test
The measured sucrose intake parameters are: in control mice, DEX 
treated and DEX+BCG treated group.
The results obtained (histogram A) show that the sucrose intake test for 
the controls is lower than that of the treated by DEX and also lower than 
that of the treated by DEX+BCG.
The analysis revealed no significant effect (p<0.05).
Body weight
The measured body weight parameters in control, DEX treated, and 
DEX+BCG treated group.
The results obtained (histogram A) show that the body weight of the 
controls is lower than that of the treated by DEX and also lower than 
that of the treatments not DEX+BCG.
The body weight gain analysis revealed a significant effect (p<0.05).
DISCUSSION
Anxiety is considered evil of the 21st century and its adverse effects will 
increasingly increase in the current model of our society. It affects one-
eighth of the total population of the world and has become an important 
field of research in neurobiology and psychopharmacology in recent 
years [20]. It generates stress: Hypervigilance and the anticipation of 
danger keep the subject constantly alert to the presence of hypothetical 
stressors.
Stress is very closely related to anxiety. In many articles, the words 
stress and anxiety overlap. Anxiogenic situations become almost a 
subcategory of stressful situations [9].
In rodents, anxiety is defined as a high level of apprehension of a new 
and unknown environment and of the increased reaction of fear [3,5]. 
When anxiety becomes abnormally intense, repetitive, prolonged, and 
inevitable, it can present a pathological form, leading to repressed 
behaviors, conditioned negative responses, poor coping strategies, 
and an increase in the sympathetic level of the autonomic nervous 
system [6].
In our experimental study, we evaluated the combined effect of DEX and 
BCG in male mice (M. musculus) that underwent behavioral testing (FST, 
EPM, TST, EPM, and sucrose test).
Fig. 4: Sucrose intake (%) Parameters in control mice, treated 
with dexamethasone (DEX), and group treated with DEX+Bacille 
Calmette–Guérin. Data are presented as mean±standard error 
of the mean. Data were analyzed by one-way analysis of variance 
and Student’s t-test. Results were considered statistically 
significant at p<0.05 (n=5)
Fig. 5: Body weight (g). In control mice, treated with 
dexamethasone (DEX), and group treated with DEX+Bacille 
Calmette–Guérin. Data are presented as mean±standard error 
of the mean. Data were analyzed by one-way analysis of variance 
and Student’s t-test. Results were considered statistically 
significant at p<0.05 (n=5)
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For the first test, which is forced swimming (FST), we observed an 
increase in immobility time in the batch treated with DEX+BCG compared 
to the control batch and a decrease in the immobile time of the batch 
treated with DEX compared to the control group. Therefore, the DEX 
causes an antidepressant effect, whereas the BCG acts in depressinogen 
at first; then, it will go directly to an antidepressant effect (Fig. 1).
Forced swimming, testing the effectiveness of antidepressants, 
represents a situation [21-27]. Mice also show active behaviors such 
as swimming and climbing. Molecules that decrease immobility time in 
forced swimming are considered to be effective antidepressants [15,28]. 
During the test of FST, antidepressants, producing a predominant 
noradrenergic or dopaminergic elevation, reduce immobility by 
increasing climbing time [29]. On the other hand, those which activate 
5-hydroxytryptamine (5HT) instead reduce immobility by the increase 
in swimming [30-32].
Connor et al. (1997) [17] were able to characterize corticotropin and 
immune responses and examine neurotransmitter levels in five regions 
of the brain at time intervals of 5, 30, 60, 90, and 120 min following 
forced swimming. They noted a significant and transient concentrations 
of noradrenaline and 5HT at the hypothalamus, 15 min after FST. The 
turnover of 5-HT significantly increased between 20 and 120 min in 
the frontal cortex and amygdala. Corticosterone showed a very high 
rate at 90 min, whereas the total number of leukocytes decreased after 
120 min, accompanied by a reduction of the percentage of lymphocytes 
between 90 and 120 min.
Concerning the labyrinth test (EPM), our results showed that there 
was an increase in the number of entries in the closed arms of the DEX-
treated patients compared to the control group and an increase in the 
DEX+BCG compared to controls as well (Fig. 2).
The plus-maze test is one of the most popular behavior patterns for 
anxiety. The increase in the number of entries and the time spent in 
the open arms are considered to be the most representative indices of 
anxiolytic activity. In this device, mice normally prefer to spend much of 
their time in the firm arms. This behavior seems to reflect an aversion 
to open arms that are generated by the fear of open spaces. Drugs that 
increase exploration of open arms are considered anxiolytic and the 
reverse is true for anxiety drugs [25,33,44].
Glucocorticoids are known to have distinct anti-inflammatory and 
immunosuppressive effects. Immunosuppression of glucocorticoids is 
mediated by a direct cytolytic effect, inhibition of lymphocyte function, 
or indirectly through soluble suppressor mediators [9].
In the caudal suspension test (TST), we observed a decrease in the 
immobility time of the DEX-treated batch and the group treated with 
the DEX+BCG combination by to the reference lot. This decrease 
is due to the effect of BCG which acts as depressinogen than as an 
antidepressant [34,35] (Fig. 3).
In addition, glucocorticoids exert inhibitory effects on the gonadotropin 
hormone-releasing hormone hypothalamic neuron and on the 
gonads by causing a reduction in the sensitivity of target tissues to 
sexual steroids (peripheral resistance) [36]. Interestingly, during 
inflammation, circulating cytokines suppress reproductive functions 
by activating the hypothalamic secretion of corticotropin-releasing 
hormone and peptides derived from proopiomelanocortin and thus 
inhibiting ovarian and testicular steroidogenesis [37,38].
It should be noted that activation of the immune system in patients 
is associated with an increase in the prevalence of depressive 
symptoms [39]. Thus, BCG induces chronic activation of the 
nervous system [11,46].
According to the sucrose test, we noticed an increase in the administered 
rate of the sweet drink of the DEX batch and the DEX+BCG group; this is 
the anhedonia index (Fig. 4).
The fact that anhedonia is one of the basic criteria for the diagnosis 
of major depression and that it can be induced in mice by the 
administration of DEX, hence, the idea that the corticosteroid plays an 
important role in the neurobiology of depression. For example, chronic 
administration of corticosterone reduces the threshold current for 
hypothalamic self-stimulation [39,40].
The last parameter analyzed was weight (body gain), we found an 
increase in the weight of male mice treated with DEX and DEX+BCG; 
this weight gain was due to the effect of DEX (Fig. 5).
DEX is sometimes illegally used with other doping agents and anabolic 
in livestock to make animals grow faster by increasing meat protein 
levels while decreasing lipid levels [10]. It is classified as a long-acting 
corticosteroid [41,45].
All aspects of the immune response may be affected, from the response 
inflammatory to the development of acquired immunity. The consequences 
of an environmental factor depend on the nature of the stressor and 
its duration (acute, repeated, or chronic), the cell type concerned 
(lymphocytes, macrophages, and polynuclear cells), and the compartment 
studied (blood, pulmonary mucosa, and digestive mucosa) [42].
If the organism is not exposed to any pathogen at the time of a stressful 
situation, stress-induced immunological alterations may have no effect 
on the health of the organism. On the other hand, if the organism must 
simultaneously cope with a viral or bacterial infection, stress can impair 
the development of an adequate immune response [43].
Finally, our results indicate that DEX causes an antidepressant effect, 
whereas BCG acts as a depressinogen in the first stage, then it goes 
directly to an antidepressant effect in the stroke of forced stroke 
without forgetting the prose of weight caused by the DEX.
CONCLUSION
According to our results, the intraperitoneal injection of DEX 
0.1 mg/kg combined with 0.2 mg/kg BCG exerted a depressinogenic 
effect following antidepressant action.
The results obtained in our work show at the level of the FST which is 
used to measure and evaluate depression, a reduction in the swimming 
time of the DEX-treated batch and of the batch treated with DEX+BCG 
and an increase in climbing time and immobility time. Therefore, the 
DEX to cause depression it is a depressive molecule because it increases 
the time of immobility.
The results for the raised cross labyrinth (EPM) test, mice place or take 
refuge in closed arms and are afraid of heights when less anxious they 
circulate freely in the open arms of the device.
However, caudal suspension test (TST) increased the immobility time 
of the DEX+BCG-treated mice compared to the control batch, while 
decreasing the mobility time in the DEX-treated mice.
As regards the sucrose test (sweet preference), an increase in the two 
batches treated with DEX+BCG compared to the control.
Body weight showed a remarkable increase in mice injected with DEX. 
Moreover, batches treated with DEX+BCG.
We conclude that the combination of DEX+ BCG seems to play a 
depressinogenic effect that will develop to become antidepressive.
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